To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Pentose phosphate pathway
The pentose phosphate pathway (also called Phosphogluconate Pathway, or Hexose Monophosphate Shunt [HMP shunt]) is a cytosolic process that serves to generate NADPH and the synthesis of pentose (5-carbon) sugars. There are two distinct phases in the pathway. The first is the oxidative phase, in which NADPH is generated, and the second is the non-oxidative synthesis of 5-carbon sugars. This pathway is an alternative to glycolysis. While it does involve oxidation of glucose, its primary role is anabolic rather than catabolic.
Located exclusively in the cytoplasm, the pathway is one of the three main ways the body creates molecules with reducing power, accounting for approximately 60% of NADPH production in humans.
One of the uses of NADPH in the cell is to prevent oxidative stress. It reduces the coenzyme glutathione, which converts reactive H2O2 into H2O. If absent, the H2O2 would be converted to hydroxyl free radicals, which can attack the cell.
The entire set of reactions can be summarized as follows:
The overall reaction for this process is:
Glucose-6-phosphate dehydrogenase is the rate-controlling enzyme of this pathway. It is allosterically stimulated by NADP+. The ratio of NADPH:NADP+ is normally about 100:1 in liver cytosol. This makes the cytosol a highly-reducing environment. Formation of NADP+ by a NADPH-utilizing pathway, thus, stimulates production of more NADPH.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pentose_phosphate_pathway". A list of authors is available in Wikipedia.|